These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17473062)

  • 1. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis.
    Ciurea SO; Merchant D; Mahmud N; Ishii T; Zhao Y; Hu W; Bruno E; Barosi G; Xu M; Hoffman R
    Blood; 2007 Aug; 110(3):986-93. PubMed ID: 17473062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
    Andréasson B; Swolin B; Kutti J
    Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.
    Giraudier S; Chagraoui H; Komura E; Barnache S; Blanchet B; LeCouedic JP; Smith DF; Larbret F; Taksin AL; Moreau-Gachelin F; Casadevall N; Tulliez M; Hulin A; Debili N; Vainchenker W
    Blood; 2002 Oct; 100(8):2932-40. PubMed ID: 12351405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis.
    Fazzi R; Pacini S; Testi R; Azzarà A; Galimberti S; Testi C; Trombi L; Metelli MR; Petrini M
    Br J Haematol; 2003 Apr; 121(1):76-85. PubMed ID: 12670334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
    Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
    Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expansion of megakaryocyte progenitors from CD34+-enriched mobilized peripheral blood stem cells is inhibited by Flt3-L.
    Case J; Hicks C; Trickett A; Kwan YL; Manoharan A
    J Interferon Cytokine Res; 2006 Feb; 26(2):76-82. PubMed ID: 16487027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.
    Delhommeau F; Dupont S; Tonetti C; Massé A; Godin I; Le Couedic JP; Debili N; Saulnier P; Casadevall N; Vainchenker W; Giraudier S
    Blood; 2007 Jan; 109(1):71-7. PubMed ID: 16954506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis.
    Le Bousse-Kerdilès MC; Martyré MC;
    Pathol Biol (Paris); 2001 Mar; 49(2):153-7. PubMed ID: 11317961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
    Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
    Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
    Herman P; Ferrant A; De Bruyère M; Straetmans N
    Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.
    Komura E; Tonetti C; Penard-Lacronique V; Chagraoui H; Lacout C; Lecouédic JP; Rameau P; Debili N; Vainchenker W; Giraudier S
    Cancer Res; 2005 Apr; 65(8):3281-9. PubMed ID: 15833861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of megakaryocytes from PIXY321 versus GM-CSF-mobilized peripheral blood progenitor cells.
    Lefebvre P; Winter JN; Rademaker AW; Goolsby C; Cohen I
    Stem Cells; 1997; 15(2):112-8. PubMed ID: 9090787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin.
    Kratz-Albers K; Scheding S; Möhle R; Bühring HJ; Baum CM; Mc Kearn JP; Büchner T; Kanz L; Brugger W
    Exp Hematol; 2000 Mar; 28(3):335-46. PubMed ID: 10720698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
    Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
    Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients.
    Vicari L; Martinetti D; Buccheri S; Colarossi C; Aiello E; Stagno F; Villari L; Cavalli M; Di Raimondo F; Gulisano M; De Maria R; Vigneri P
    Br J Haematol; 2012 Oct; 159(2):237-40. PubMed ID: 22924455
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis.
    Vannucchi AM; Pancrazzi A; Guglielmelli P; Di Lollo S; Bogani C; Baroni G; Bianchi L; Migliaccio AR; Bosi A; Paoletti F
    Am J Pathol; 2005 Sep; 167(3):849-58. PubMed ID: 16127162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.